FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to oncology, and concerns process of vascularisation modulation that is ensured by introduction of signal pathway inhibitor TF-VIIa in effective amount. As such inhibitor, an active centre of the inhibited factor VIIa (VIlai) or an antibody specific to factor VIIa.
EFFECT: method ensures inhibition of pathological vascularisation, including in tissues of malignant tumours.
4 cl, 9 dwg, 4 ex
